Haptena Therapeutics S.r.l.
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $3.5M
Investors
- 1
About Haptena Therapeutics S.r.l.
l. is engaged in the development of immunotherapies aimed at addressing genetically defined cancers.Haptena Therapeutics specializes in developing next-generation immunotherapies tailored for genetically defined cancers, with a primary focus on KRAS-driven tumors. The company integrates the precision of targeted therapies with the transformative potential of immune-based treatments to address the limitations of existing cancer therapies. Their core product offerings aim to enhance treatment efficacy for oncogenes, which are often inadequately addressed by current solutions. By targeting mechanisms of resistance and tumor adaptation, Haptena seeks to deliver innovative treatment options that provide more durable responses for patients facing challenging tumors.Haptena Therapeutics generates revenue through strategic partnerships and collaborations aimed at advancing its proprietary therapies for KRAS-driven cancers. Transactions typically occur through agreements with pharmaceutical companies and research institutions, facilitating the development and potential commercialization of their innovative products. Revenue streams may include milestone payments, licensing fees, and royalties derived from successful product launches and market penetration. The company's flagship offerings are likely to be included in these partnership agreements, enabling the alignment of interests with various stakeholders in the oncology field.l. The company plans to introduce upcoming products designed to enhance treatment options by targeting new mechanisms of resistance in cancer therapy. Additionally, Haptena aims to expand its market presence beyond Europe, looking toward potential opportunities in North America and Asia by late 2026.
Who invested in Haptena Therapeutics S.r.l.
1 investor across 1 round
See all investors in Haptena Therapeutics S.r.l.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 8, 2025
Amount
$3.5M
Investors
Questions about Haptena Therapeutics S.r.l.
Who invested in Haptena Therapeutics S.r.l.?
Haptena Therapeutics S.r.l. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haptena Therapeutics S.r.l. raised?
Haptena Therapeutics S.r.l. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Haptena Therapeutics S.r.l. last raise money?
Haptena Therapeutics S.r.l.'s most recent round on record is a Seed, in Dec 2025.
What does Haptena Therapeutics S.r.l. do?
Haptena Therapeutics S.r.l. is a healthcare specialists company.
Where is Haptena Therapeutics S.r.l. headquartered?
Haptena Therapeutics S.r.l. is headquartered in Turin, Italy.
Which VCs invest in companies like Haptena Therapeutics S.r.l.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare specialists companies at Haptena Therapeutics S.r.l.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Haptena Therapeutics S.r.l.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.